Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Immutep (IMMP) Operating Expenses (2016 - 2020)

Immutep filings provide 5 years of Operating Expenses readings, the most recent being $17832.2 billion for Q2 2020.

  • On a quarterly basis, Operating Expenses rose 2.61% to $17832.2 billion in Q2 2020 year-over-year; TTM through Dec 2021 was $17832.2 billion, a 49.36% decrease, with the full-year FY2025 number at $5.5 million, down 5.11% from a year prior.
  • Operating Expenses hit $17832.2 billion in Q2 2020 for Immutep, up from $17378.8 billion in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $17832.2 billion in Q2 2020 to a low of -$958713.3 in Q1 2017.
  • Median Operating Expenses over the past 4 years was $7.4 million (2016), compared with a mean of $5868.5 billion.
  • Biggest five-year swings in Operating Expenses: soared 100.39% in 2016 and later plummeted 36.01% in 2017.
  • Immutep's Operating Expenses stood at $9.1 million in 2016, then tumbled by 36.01% to $5.8 million in 2017, then surged by 299313485.59% to $17378.8 billion in 2019, then rose by 2.61% to $17832.2 billion in 2020.
  • The last three reported values for Operating Expenses were $17832.2 billion (Q2 2020), $17378.8 billion (Q2 2019), and $5.8 million (Q2 2017) per Business Quant data.